Fundraising Fox

Rxpost

Founded 2021 · 21 employees on LinkedIn · 3 known investors

RxPost operates a DSCSA-compliant pharmacy-to-pharmacy marketplace paired with cloud-based inventory software, letting independent pharmacies share or source surplus medications and track stock across multiple stores. It targets independent and community pharmacies looking to reduce waste and improve margins.

Also known as RxPost · RxPost Inc.

Founders & leadership

Rxpost was founded in 2021 by Amantha Bagdon.

ABAmantha Bagdon
Amantha BagdoninFounder

Investors · 3

Company profile

researched Aug 2026

RxPost Inc. operates a DSCSA-compliant online marketplace and cloud inventory platform for licensed independent pharmacies. Members list surplus medications for sale to other verified pharmacies and source lower-cost or hard-to-find drugs from the network, with the platform generating audit-ready transfer documentation for each transaction. Alongside the marketplace, RxPost provides inventory-management software that tracks on-hand stock, lot numbers, expiration dates and reorder points, benchmarks prices automatically against wholesale acquisition cost (WAC), and lets multi-store operators link locations under a master login, view a chain dashboard and record internal transfers.

The service runs in a browser with no special hardware required, though a barcode scanner can speed up listing; inventory can be imported by CSV or synced from supported pharmacy management systems, and users can export inventory and transaction records. Controlled substances, items tied to government discount programs such as 340B, and other NDCs prohibited by DSCSA or state law are blocked from listing. Buyers search by NDC or drug name, check out with FedEx 2-Day, Priority Overnight or free local pick-up, and unfilled needs can be posted as requests that alert the network when matching stock appears. Payments are routed through a SOC 2 Type II ACH environment, with Dwolla Platform accounts used for payment functionality under the terms of service.

Founding story

Amantha Bagdon, a former pharmacy technician with about 20 years in community pharmacy, developed the idea while working at an independent pharmacy in Los Angeles after observing usable medication being discarded at one store while nearby pharmacies paid a premium for the same drugs. She founded RxPost to replace the ad hoc phone, email and paper purchase-order system pharmacies used to trade inventory.

Business model

RxPost operates a two-sided B2B marketplace connecting licensed independent pharmacies as buyers and sellers, combined with subscription software tiers for inventory and multi-store management. Buyers and sellers contract directly with each other; RxPost states it is not a party to the underlying sale.

A free Starter tier allows unlimited listings and charges a 10% fee only when an item sells. Paid subscription tiers (including Scale and Enterprise) add white-glove or priority support and multi-store tools; annual billing is discounted roughly 20% versus monthly. There are no setup or listing charges; payouts and charges run through ACH, with card payment accepted for subscription tiers.

Traction

The company reports more than 900 independent pharmacies on the network and coverage across 34 U.S. states. Following participation in Slauson & Co.'s Friends & Family accelerator in 2024 and expansion into New York, RxPost reported revenue growth of roughly 4,882% year over year. Site-published averages include $12,294+ saved in a customer's first 30 days, $80.8K+ in cash from surplus in the first 60 days, $60.8K+ in annual inventory-cost savings, an 11.1-percentage-point gross margin lift, and a 21.8% average discount versus WAC.

Latest developments

Proceeds from the pre-seed round are being applied to hiring pharmacy-experienced customer success staff and building out the engineering team around founding engineer Brendan Hoffman. The founder has indicated the company will likely begin raising a seed round within roughly 18 months of the pre-seed close.

Full profile — market position, technology, go-to-market, geography, history, risks & controversies

Market position

RxPost positions itself as a licensed-pharmacy-only, compliance-focused alternative to the informal phone-, email- and paper-PO-based networks independents use to trade near-expiry or surplus medications, and as an inventory-control option for stores that lack enterprise systems. It states that ownership and data remain with pharmacies.

Verified licensed-pharmacy-only membership, DSCSA-oriented audit-ready transfer records, transparent fees with a free listing tier, automatic WAC price benchmarking, combined marketplace plus multi-store inventory tracking, and a team drawn from community pharmacy practice.

Technology

Browser-based platform with responsive mobile support, barcode-scanner-assisted listing, CSV import and pharmacy management system integrations, automated NDC pricing and WAC benchmarking, automatic flagging of disallowed NDCs, and stated plans around AI-driven demand forecasting, instant DEA license checks and auto-bundled lots. Traffic is TLS 1.3-encrypted and served through AWS WAF and CloudFront; payout data is held in a SOC 2 Type II environment and full bank details are not stored by RxPost.

Go-to-market

Self-service signup with license verification in about five minutes, supported by demo bookings and 20-minute discovery calls, a customer success team staffed by former pharmacy technicians, and account executives and sales staff. The company also reaches pharmacies through founder involvement in pharmacy associations and accelerator networks.

Licensed independent and community pharmacies in the United States, including single-store owners, pharmacists-in-charge, and small multi-store groups seeking to reduce stockouts, liquidate surplus inventory and lower acquisition costs.

Geography

United States; the company states it serves licensed independent pharmacies in 34 states, with customer testimonials from California and New York and reported expansion into the New York market. The founder came up with the concept while working in Los Angeles.

History

RxPost began as a pharmacy-only marketplace for surplus drugs and later added inventory-management software. It went through Slauson & Co.'s Friends & Family accelerator in 2024, opened a pre-seed round the same year that closed oversubscribed at more than $1 million, and expanded into New York state. Its terms of service were last updated on 2025-12-18.

Risks & controversies

The marketplace depends on compliance with DSCSA and state pharmacy transfer rules; controlled substances and 340B-program items cannot be listed. RxPost's terms state that buyers and sellers contract directly with one another, that RxPost is not a party to those transactions, and that users bear the risks of dealing with counterparties. Payment functionality requires users to open a Dwolla Platform account. Performance figures published on the company website are self-reported.

Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
Average annual inventory-cost savingsJan 2026$60.8K
Average cash from surplus in first 60 daysJan 2026$80.8K
Average customer savings in first 30 daysJan 2026$12.3K
Average discount vs WACJan 202621.8%
Gross margin liftJan 202611.1%
Independent pharmacies on platformJan 2026900 pharmacies
Marketplace transaction feeJan 202610%
Revenue growth year over yearJan 20244,882%
US states servedJan 202634 states

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Timeline · 3

launches, deals, and filings
Jan 2024
Expansion into New York state market

Revenue growth coincided with RxPost's expansion into the New York state market and adoption by new customers.

source ↗

Jan 2024
RxPost raises oversubscribed pre-seed round of more than $1 million

Founder and CEO Amantha Bagdon opened a pre-seed round in 2024; RxPost raised more than $1 million (reported as a $1.1 million round) from institutional investors and individual angels, with proceeds earmarked for pharmacy-expert customer success hires and the engineering team.

$1.1M source ↗

Jan 2024
Participated in Slauson & Co. Friends & Family accelerator

RxPost ran its business-to-business marketplace through Slauson & Co.'s Friends & Family accelerator in 2024.

source ↗

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

Research sources · 8

primary sources listed

8 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Rxpost do?
RxPost runs a DSCSA-compliant pharmacy-to-pharmacy marketplace and inventory software for independent pharmacies.
Who founded Rxpost?
Rxpost was founded by Amantha Bagdon in 2021.
Who are Rxpost's investors?
Rxpost's investors include Slauson & Co., Stone Mountain Ventures, Capitalize VC.